🚨 Last chance! Join the IFCCA Academy’s 2nd online module with FIBROTARGET: 🎥 Living with Fibrosis: Challenges, Treatments & Innovations Learn about the latest in intestinal fibrosis with expert & patient insights. ⏰ Register by 3 Nov: https://t.co/nGDXmcdsnj

🎤 FIBROTARGET at the 3rd International Workshop on Liver & Gut Fibrosis in Valencia! Earlier this month, FIBROTARGET's Gianluca Matteoli (@KU_Leuven) & Elena Ricart (@hospitalclinic) presented, joining experts driving forward fibrosis research. More➡️ https://t.co/SvDkjFiJWi

💡FIBROTARGET at #UEGWeek2025! In Berlin, our session “From bench to bedside in fibrosis innovation” brought together @KU_Leuven, IFCCA, patient advocates & clinicians to discuss advances in IBD fibrosis and next steps towards clinical trials. More➡️ https://t.co/hMFmG2XzoO

🌟 Join us at #UEGWeek 2025 in Berlin! FIBROTARGET partners will be there to discuss the latest in fibrosis innovation and patient-centred trial design. Don’t miss the opportunity to connect and explore how we’re advancing research in intestinal fibrosis! #IBD #FibrosisResearch

📣FIBROTARGET will be at #UEGWeek 2025 in Berlin! We’ll share progress on advancing research into intestinal fibrosis and fibrostenosis in Crohn’s disease. Stay tuned for details on where to find us! #UEGWeek #FIBROTARGET #CrohnsDisease #IntestinalFibrosis

🔍 Interested in the latest advances in intestinal fibrosis research? Stay updated with cutting-edge findings, project news & events by signing up for the FIBROTARGET newsletter. Designed for researchers, clinicians & the wider community. Join here ➡️ https://t.co/nlRdS7zcZi

Looking for reliable info on intestinal fibrosis? The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian! Created with and for the community with @efcca. Download your copy👇 👉 https://t.co/YF6RvWLVfo

Have you heard the news?🎉 FIBROTARGET coordinator Prof Séverine Vermeire is now the first female rector of KU Leuven in 600 years! Prof Gianluca Matteoli takes over as coordinator with Prof Bram Verstockt & FIBROTARGET colleagues across Europe. More➡️ https://t.co/dvYg9yMJPZ

📚 Looking for scientific publications on intestinal fibrosis? We’ve updated the FIBROTARGET publications page! Now you can easily browse all peer-reviewed research from the project in one place. 🔗 Explore the page➡️: https://t.co/fBjtmqrZYR #IBDresearch #Fibrosis

🎥 “You are everything else, and you are chronically ill.” Patient advocate Anastasia Ntanou's story is a powerful reminder: being a patient is just one part of who you are. 💬 Read their full story via FIBROTARGET: https://t.co/jwAP5sfYAR #PatientVoices #FibrosisAwareness

📣 New from FIBROTARGET! Can JAK-STAT signalling help treat IBD fibrosis? A new review by KU Leuven explores how this immune pathway - already targeted in IBD - might also reduce fibrosis by acting on fibroblasts. 🔗 Read more: https://t.co/YtKIt0NUG9 #IBD #Fibrosis

🌟 Young Talent Spotlight! In this short interview, PhD student Gaia Zanella shares insights into her work, the challenges of studying intestinal fibrosis, and the novel research approaches being explored by FIBROTARGET researchers. 🧪 Read more ➡️ https://t.co/ajZ3tTAJGi

🔍Introducing #FIBROTARGET Info Pills! We’re breaking down key #IBD & #Fibrosis concepts in simple terms—starting with: What is IBD-related fibrosis? 💡 Many hear the word—but what does it actually mean, and how does it influence disease progression? 🌐 https://t.co/djx818T6xe

🌍 FIBROTARGET Patient Stories Meet Anastasia, a patient advocate from Greece living with fibrotic #CrohnsDisease for 15+ years. She shares her story, tackles misconceptions & offers advice for others with the condition. 📖 Read more: https://t.co/jwAP5sfYAR

🌍 Missed our World IBD Day 2025 campaign? FIBROTARGET joined EFCCA’s #IBDHasNoBorders campaign to #BreakTaboos around intestinal fibrosis — a hidden IBD complication. 👉 Catch up on the campaign here: https://t.co/6EQpDaCc74 #WorldIBDDay #Fibrosis #PatientVoices

📬 Stay in the loop with the FIBROTARGET newsletter! Get updates on publications, project news, patient stories & events — straight to your inbox, twice a year. Next issue lands next week! 📩 Subscribe now: https://t.co/nlRdS7zcZi #IBD #fibrosis #research

Taboos thrive in silence — but science can help break them. Across Europe, FIBROTARGET researchers are working together to understand IBD fibrosis, improve outcomes, and encourage open conversations. #IBDHasNoBorders 🔗Discover the latest: https://t.co/6jESAXd0Wx

Today is #WorldIBDDay2025. We’re proud to stand with @EFCCA in saying: #IBDHasNoBorders — Breaking Taboos, Talking About It. From silent symptoms to fibrotic complications, it’s time to speak up and be heard. 🔗 Discover the campaign: https://t.co/uyiolJv6xZ

IBD is more than flare-ups. Many live with fatigue, surgery & hidden issues like fibrosis. To help #BreakTaboos, Anastasia Ntanou shares her story & misconceptions she’s faced. With EFCCA, FIBROTARGET puts patient voices first. 📹Watch: https://t.co/gF6gwBPQJw #WorldIBDDay2025

🔬 FIBROTARGET at Digestive Disease Week 2025! Earlier this month, FIBROTARGET was well represented at #DDW2025 in San Diego. Great to see FIBROTARGET's work on the future of intestinal #fibrosis in IBD being discussed on a global stage! #FIBROTARGET #EUresearch